In situ profiling of plasma cell clonality with image-based single-cell transcriptomics

Evan Yang1,2, Jose Aceves-Salvador1,2, Carlos Castrillon1

  • 1Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.

Insights

New BCR-MERFISH technology identifies plasma cell clones by V-gene usage. This method reveals microbiota-driven changes in mouse gut plasma cells, enhancing our understanding of adaptive immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genomics

Background:

  • Single-cell transcriptomics identifies cell types but misses functional variation in adaptive immunity due to unique immune receptors.
  • V(D)J recombination creates diverse B-cell receptors within the same cell type, a key aspect not captured by current methods.

Purpose of the Study:

  • To introduce a novel method, B-cell-receptor multiplexed error robust fluorescence in situ hybridization (BCR-MERFISH), for distinguishing plasma cell clones.
  • To analyze plasma cell diversity and distribution in response to microbiota in the mouse gut.

Main Methods:

  • Developed BCR-MERFISH to combine V-gene usage with transcriptome profiling for plasma cell identification.
  • Validated BCR-MERFISH in cell culture and in mice with varying plasma cell diversity.
  • Applied BCR-MERFISH to study mouse gut plasma cells and their response to microbiota.

Main Results:

  • BCR-MERFISH accurately identifies V-gene usage in various settings.
  • Revealed microbiota-dependent alterations in plasma cell abundance and clonal diversity in the mouse gut.
  • Demonstrated non-uniform spatial distribution of plasma cell clones along the mouse ileum.

Conclusions:

  • BCR-MERFISH provides a powerful tool to dissect plasma cell heterogeneity and function.
  • The study highlights the impact of microbiota on adaptive immunity and plasma cell dynamics.
  • BCR-MERFISH is anticipated to offer new insights into diverse immunological questions by integrating tissue context.

Related Concept Videos